Pneumonia associated with mechanical ventilation. Update and recommendations inter- Societies SADI-SATI

Representatives of the Argentine Society of Infectious Diseases (SADI) and the Argentine Society of Intensive Therapy (SATI) worked together on the development of specific recommendations for the diagnosis, treatment and prevention of ventilator-associated pneumonia (VAP). The methodology used was t...

Full description

Saved in:
Bibliographic Details
Published inMedicina (Buenos Aires) Vol. 78; no. 2; pp. 99 - 106
Main Authors Cornistein, Wanda, Colque, Ángel M, Staneloni, María Inés, Monserrat Lloria, María, Lares, Mónica, González, Ana Laura, Fernández Garcés, Alejandro, Carbone, Edith
Format Journal Article
LanguageSpanish
Published Argentina 2018
Subjects
Anti-Bacterial Agents - classification
Anti-Bacterial Agents - therapeutic use
Humans
Intensive Care Units
Pneumonia, Ventilator-Associated - diagnosis
Pneumonia, Ventilator-Associated - drug therapy
Pneumonia, Ventilator-Associated - prevention & control
Respiration, Artificial - adverse effects
Risk Factors
treatment
diagnosis
pneumonia
ventilator
prevention
Online AccessGet full text

Cover

More Information
Summary:Representatives of the Argentine Society of Infectious Diseases (SADI) and the Argentine Society of Intensive Therapy (SATI) worked together on the development of specific recommendations for the diagnosis, treatment and prevention of ventilator-associated pneumonia (VAP). The methodology used was the analysis of the literature published in the last 15 years, complemented with the opinion of experts and local data. This document aims to offer basic tools to optimize diagnosis based on clinical and microbiological criteria, orientation in empirical and targeted antibiotic schemes, news on posology and administration of antibiotics in critical patients and to promote effective measures to reduce the risk of VAP. It also offers a diagnostic and treatment algorithm and considerations on inhaled antibiotics. The joint work of both societies -infectious diseases and intensive care- highlights the concern for the management of VAP and the importance of ensuring improvement in daily practices. This guideline established recommendations to optimize the diagnosis, treatment and prevention of VAP in order to reduce morbidity and mortality, days of hospitalization, costs and resistance to antibiotics due to misuse of antimicrobials.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0025-7680